Page last updated: 2024-08-23

etoposide and Carcinoma, Large Cell

etoposide has been researched along with Carcinoma, Large Cell in 45 studies

Research

Studies (45)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (8.89)	18.2507
2000's	13 (28.89)	29.6817
2010's	22 (48.89)	24.3611
2020's	6 (13.33)	2.80

Authors

Authors	Studies
Economidou, SC; Fotopoulos, G; Vrontis, K	1
Chen, Y; Han, B; Hu, M; Qian, F; Wang, Y; Yang, Z; Zhang, W; Zhang, Y	1
Fukuhara, M; Matsumura, Y; Mine, H; Muto, S; Okabe, N; Ozaki, Y; Shio, Y; Suzuki, H; Takagi, H; Watanabe, M; Yamaguchi, H	1
Griswold, D; Nakamoto, K; Sanabria, J; Weaver, A	1
Abbas, HA; An, T; Chang, L; Chen, H; Chen, R; Chen, W; Dong, Z; Futreal, PA; Glisson, BS; Gong, Y; Guan, Y; Heymach, JV; Hong, L; Kalhor, N; Lee, JJ; Lewis, J; Li, J; Li, Z; Rinsurongkawong, W; Roarty, EB; Roth, JA; Swisher, SG; Wang, J; Wang, Y; Wang, Z; Wistuba, II; Wu, M; Wu, N; Xia, X; Yang, L; Yang, X; Yi, X; Zhang, J; Zhao, J; Zhong, J; Zhu, X; Zhuo, M	1
Huang, M; Jiang, L; Qin, Y; Yu, M; Zhou, L	1
Azzopardi, N; Babic, D; Delicata, NP; Montebello, A; Zahra Bianco, E	1
Damhuis, RA; den Bakker, MA; Derks, JL; Dingemans, AC; Groen, HJ; Smit, EF; Speel, EM; Thunnissen, E; van den Broek, EC; van Suylen, RJ	1
Hope, AJ; Papp, S; Perez-Ordóñez, B; Wasserman, JK	1
Chen, CA; Chen, YL; Cheng, WF; Lin, MC; Tu, YA	1
Cheng, WH; Ho, CH; Lee, WH; Tzou, KY	1
Hata, K; Hidaka, T; Iwasaki, Y; Matsuhashi, A; Okuzumi, S; Shimizu, S; Takahashi, H	1
Berard, H; Boffa, S; Chouaid, C; Damotte, D; Le Caer, H; Le Treut, J; Lena, H; Monnet, I; Sault, MC; Souquet, PJ; Vergnenegre, A	1
Boutzios, G; Chatzellis, E; Kaltsas, G; Koumarianou, A; Tsavaris, N	1
Daoud, J; Elloumi, F; Fourati, N; Frikha, M; Ghorbel, A; Ghorbell, L; Jlidi, R; Siala, W	1
Ayala, AG; Choi, EK; Divatia, M; Miles, BJ; Okoye, E; Ro, JY	1
Hur, GY; Kang, EJ; Kang, KH; Kim, JS; Lee, SY; Min, KH; Oh, SC; Seo, JH; Shim, JJ	1
Ameratunga, M; du Plessis, J; Gan, H; Lee, WI	1
Becker, M; Fichtner, I; Hammer, S; Hoffmann, J; Merk, J; Rolff, J; Sommer, A; Soong, R	1
Coosemans, W; De Leyn, P; Decaluwé, H; Decker, G; Lerut, T; Lievens, Y; Moons, J; Nafteux, P; Van Raemdonck, D; Vansteenkiste, J	1
Chan, MY; Leung, CW; Li, WW; Pong, WM; Yau, TN	1
Bao, QL; Chen, P; Dai, CH; Li, J; Li, XQ	1
Hiroshima, K; Iwadate, Y; Iyoda, A; Moriya, Y; Nakatani, Y; Takiguchi, Y; Uno, T; Yoshino, I	1
Baldi, A; Beleford, D; Boccellino, M; Liu, Z; Maguire, J; Molina, J; Quagliuolo, L; Rattan, R; Shridhar, V; Staub, J	1
Feigenberg, S; Huang, CH; Jotte, RM; Langer, CJ; Monberg, MJ; Movsas, B; Obasaju, CK; Ross, HJ; Wang, L; Xu, F	1
Gupta, A; Mittal, B; Natu, SM; Negi, MP; Prasad, R; Srivastava, AN; Srivastava, S	1
Abbruzzese, A; Addeo, R; Apollinari, S; Basile, A; Bestoso, E; Botta, C; Caraglia, M; Correale, P; Gotti, G; Lamberti, M; Licchetta, A; Luzzi, L; Martellucci, I; Misso, G; Pagliuchi, M; Romano, O; Rotundo, MS; Tagliaferri, P	1
Isowa, N; Izumi, H; Miura, H; Sakaguchi, Y; Shimizu, E; Takeda, K; Tokuyasu, H	1
Chen, CP; Jablons, DM; Jahan, TM; Weinberg, VK; Yom, SS	1
Abedallaa, N; Baey, C; Besse, B; de Montpreville, VT; Fabre, D; Guigay, J; Pechoux, CL; Pignon, JP; Planchard, D; Soria, JC; Tremblay, L	1
Comans, EF; Hartemink, KJ; Paul, MA; Phernambucq, EC; Postmus, PE; Senan, S; Smit, EF	1
Acker, T; Banik, N; Bogenrieder, T; Eberhardt, F; Eschbach, C; Fink, TH; Heigener, DF; Huber, RM; Hummler, S; Ittel, T; Schroeder, M; Schweisfurth, H; Steinhauer, EU; Virchow, JC; Waller, C; Wolf, M	1
Aiello, E; Colarossi, C; Costanzo, R; Giuffrida, D; Martinetti, D; Memeo, L; Pino, P	1
Fujimoto, N; Fujiwara, K; Hamazaki, S; Kiura, K; Kozuki, T; Mizobuchi, K; Shiomi, K; Tabata, M; Tanimoto, M; Ueoka, H	1
Asamura, H; Kodama, T; Kunitoh, H; Matsuno, Y; Ohe, Y; Saijo, N; Sekine, I; Takei, H; Tamura, T; Tsuchiya, R; Yamamoto, N; Yamazaki, S	1
Cho, EK; Heo, DS; Jung, KH; Kim, JH; Kim, SY; Kim, YH; Lim, HY; Park, BJ; Park, K; Ryoo, BY; Suh, CW	1
Berishvili, G; Blum, WF; Figge, AM; Flyvbjerg, A; Frystyk, J; Klöppel, G; Lankisch, PG; Nauck, MA; Perren, A; Reinecke, M; Schmiegel, W; Zapf, J; Zwimpfer, C	1
Hotta, K; Ichimura, K; Kiura, K; Matsuoka, J; Osawa, M; Tabata, M; Takigawa, N; Tanimoto, M	1
Fujiwara, Y; Kunitoh, H; Nokihara, H; Ohe, Y; Sekine, I; Tamura, T; Tsuta, K; Yamada, K; Yamamoto, N	1
Beltrán, M; Canals, E; Dorca, J; Fuentes, R; Izquierdo, A; Viladiu, P	1
Abe, S; Fujita, A; Hayashi, I; Kawakami, Y; Kurita, Y; Matsuda, T; Nakabayashi, T; Nishiwaki, Y; Noda, K; Oshita, F; Saijo, N; Suzuki, S; Takahashi, S; Tamura, T; Tobise, K; Tsuchiya, S	1
Zukowska, H; Zwoliński, J	1
Andras, EJ; Byhardt, RW; Graham, ML; Roach, M; Scott, C; Smith, C; Werner-Wasik, M	1
Koshiishi, H; Takahashi, E; Tamamoto, F; Utsumi, K	1
Fickers, M; Goei, R; Theunissen, P	1

Reviews

4 review(s) available for etoposide and Carcinoma, Large Cell

Article	Year
Large cell neuroendocrine carcinoma of the endometrium: A case report and literature review. Taiwanese journal of obstetrics & gynecology, 2018, Volume: 57, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Endometrial Neoplasms; Endometrium; Etoposide; Female; Humans; Middle Aged; Salvage Therapy	2018
Current concepts in the diagnosis and management of poorly differentiated gastrointestinal neuroendocrine carcinomas. Endokrynologia Polska, 2013, Volume: 64, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Colonic Neoplasms; Diagnosis, Differential; Diagnostic Imaging; Etoposide; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Platinum Compounds; Prognosis; Receptors, Somatostatin; Retrospective Studies; Small Cell Lung Carcinoma	2013
De novo large cell neuroendocrine carcinoma of the prostate gland with pelvic lymph node metastasis: a case report with review of literature. International journal of clinical and experimental pathology, 2014, Volume: 7, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Cystoscopy; Disease Progression; Etoposide; Fatal Outcome; Humans; Immunohistochemistry; Laparoscopy; Leuprolide; Lymph Node Excision; Lymphatic Metastasis; Male; Meningeal Neoplasms; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Paclitaxel; Pelvis; Prostatic Neoplasms; Robotic Surgical Procedures; Time Factors; Tomography, X-Ray Computed; Transurethral Resection of Prostate; Treatment Outcome	2014
Primary large cell neuroendocrine carcinoma of the presacral region. Journal of clinical pathology, 2001, Volume: 54, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Cisplatin; Etoposide; Fatal Outcome; Female; Humans; Middle Aged; Pelvic Neoplasms; Sacrum	2001

Trials

8 trial(s) available for etoposide and Carcinoma, Large Cell

Article	Year
Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies	2013
Randomized phase II trial of cisplatin, etoposide, and radiation followed by gemcitabine alone or by combined gemcitabine and docetaxel in stage III A/B unresectable non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2010, Volume: 5, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Docetaxel; Etoposide; Feasibility Studies; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiotherapy Dosage; Survival Rate; Taxoids; Treatment Outcome	2010
Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients. Cancer biology & therapy, 2011, Jul-15, Volume: 12, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging	2011
Topotecan/cisplatin compared with cisplatin/etoposide as first-line treatment for patients with extensive disease small-cell lung cancer: final results of a randomized phase III trial. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2012, Volume: 7, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Prognosis; Small Cell Lung Carcinoma; Topotecan	2012
Randomized phase II study of gemcitabine plus cisplatin versus etoposide plus cisplatin for the treatment of locally advanced or metastatic non-small cell lung cancer: Korean Cancer Study Group experience. Lung cancer (Amsterdam, Netherlands), 2006, Volume: 52, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Korea; Lung Neoplasms; Male; Middle Aged; Survival Rate; Treatment Outcome	2006
Phase II trial of carboplatin in combination with etoposide in locally advanced large cell carcinoma and adenocarcinoma of the lung. Lung cancer (Amsterdam, Netherlands), 1995, Volume: 12, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged	1995
Phase II study of irinotecan and etoposide in patients with metastatic non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged	1997
[Evaluation of bronchial arterial infusion (BAI) for high risk lung cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:12 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Camptothecin; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intra-Arterial; Irinotecan; Lung Neoplasms; Male; Middle Aged	2000

Other Studies

33 other study(ies) available for etoposide and Carcinoma, Large Cell

Article	Year
Platinum Doublet plus Atezolizumab as First-line Treatment in Metastatic Large Cell Neuroendocrine Carcinoma: A Single Institution Experience. Cancer investigation, 2022, Volume: 40, Issue:2 Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Platinum; Prospective Studies; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis; Treatment Outcome	2022
Combined large cell neuroendocrine carcinoma: clinical characteristics, prognosis and postoperative management. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2022, 07-11, Volume: 62, Issue:2 Topics: Adenocarcinoma; Adult; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Etoposide; Female; Humans; Lung Neoplasms; Neoplasm Staging; Prognosis; Retrospective Studies	2022
Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report. Thoracic cancer, 2022, Volume: 13, Issue:19 Topics: Aged; Anaplastic Lymphoma Kinase; Antibodies, Monoclonal, Humanized; B7-H1 Antigen; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; ErbB Receptors; Etoposide; Humans; Immune Checkpoint Inhibitors; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local	2022
Large-Cell Neuroendocrine Carcinoma of the Gallbladder: A Rare Case. The American surgeon, 2019, Jul-01, Volume: 85, Issue:7 Topics: Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Gallbladder Neoplasms; Humans; Mastectomy, Segmental; Radiotherapy; Treatment Outcome	2019
The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 02-15, Volume: 26, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cell-Free Nucleic Acids; Deoxycytidine; Etoposide; Female; Gemcitabine; Genomics; High-Throughput Nucleotide Sequencing; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Organoplatinum Compounds; Pemetrexed; Prognosis; Survival Rate; Taxoids	2020
Durable response to combination radiotherapy and immunotherapy in EP-resistant lung large-cell neuroendocrine carcinoma with Immunotherapy, 2020, Volume: 12, Issue:4 Topics: AMP-Activated Protein Kinase Kinases; beta 2-Microglobulin; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemoradiotherapy; Drug Resistance, Neoplasm; Etoposide; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Ipilimumab; Lung Neoplasms; Male; Middle Aged; Mutation; Nivolumab; Protein Serine-Threonine Kinases; Radiosurgery; Treatment Outcome	2020
Large cell neuroendocrine carcinoma arising from the anterior mediastinum. BMJ case reports, 2021, May-25, Volume: 14, Issue:5 Topics: Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Etoposide; Female; Humans; Mediastinum; Middle Aged; Prognosis	2021
Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter? The European respiratory journal, 2017, Volume: 49, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Docetaxel; Etoposide; Female; Gemcitabine; Humans; Male; Middle Aged; Netherlands; Paclitaxel; Pemetrexed; Registries; Small Cell Lung Carcinoma; Taxoids; Vinblastine; Vinorelbine	2017
Epstein-Barr Virus-Positive Large Cell Neuroendocrine Carcinoma of the Nasopharynx: Report of a Case with Complete Clinical and Radiological Response After Combined Chemoradiotherapy. Head and neck pathology, 2018, Volume: 12, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemoradiotherapy; Cisplatin; Epstein-Barr Virus Infections; Etoposide; Humans; Male; Nasopharyngeal Neoplasms; Tuberous Sclerosis	2018
Primary large cell neuroendocrine carcinoma of the prostate in a hormone naive patient: A case report from Taiwan. Journal of cancer research and therapeutics, 2018, Volume: 14, Issue:Supplement Topics: Aged; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Humans; Male; Prostate; Prostatic Neoplasms; Taiwan; Transurethral Resection of Prostate	2018
Large Cell Neuroendocrine Carcinoma of the Mediastinum Successfully Treated with Systemic Chemotherapy after Palliative Radiotherapy. Internal medicine (Tokyo, Japan), 2019, Feb-15, Volume: 58, Issue:4 Topics: Aged; Antineoplastic Agents; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Mediastinum; Treatment Outcome	2019
[Large cell neuroendocrine carcinoma of the nasopharynx: A case report]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2014, Volume: 18, Issue:3 Topics: Adult; Antineoplastic Agents; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Fatal Outcome; Humans; Male; Meningeal Neoplasms; Nasal Obstruction; Nasopharyngeal Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Tinnitus	2014
Comparison of the Efficacy between Pemetrexed plus Platinum and Non-Pemetrexed plus Platinum as First-Line Treatment in Patients with Wild-Type Epidermal Growth Factor Receptor Nonsquamous Non-Small Cell Lung Cancer: A Retrospective Analysis. Chemotherapy, 2016, Volume: 61, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; ErbB Receptors; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Mutation; Neoplasm Staging; Pemetrexed; Prognosis; Retrospective Studies; Survival Rate; Vinblastine; Vinorelbine	2016
Hypopharyngeal large cell neuroendocrine carcinoma. BMJ case reports, 2015, Dec-29, Volume: 2015 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Endoscopy, Gastrointestinal; Etoposide; Fatal Outcome; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Laryngoscopy; Male; Middle Aged; Treatment Outcome	2015
Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers. Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Oct-15, Volume: 14, Issue:20 Topics: Adenocarcinoma; Adult; Aged; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cetuximab; Deoxycytidine; Disease Models, Animal; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Etoposide; Female; Gemcitabine; Gene Expression Profiling; Genes, ras; Humans; Immunoblotting; Lung Neoplasms; Male; Mice; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Middle Aged; Mutation; Oligonucleotide Array Sequence Analysis; Paclitaxel; Polymerase Chain Reaction; Prognosis; Protein Kinase Inhibitors; Quinazolines; Radiation-Sensitizing Agents; Small Cell Lung Carcinoma; Tumor Suppressor Protein p53; Vinblastine; Vinorelbine; Xenograft Model Antitumor Assays	2008
Survival after trimodality treatment for superior sulcus and central T4 non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, Volume: 4, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pneumonectomy; Prognosis; Prospective Studies; Radiotherapy Dosage; Remission Induction; Survival Rate; Tomography, X-Ray Computed	2009
Large-cell neuroendocrine carcinoma of the uterine cervix complicating pregnancy. Hong Kong medical journal = Xianggang yi xue za zhi, 2009, Volume: 15, Issue:1 Topics: Abortion, Induced; Adult; Antineoplastic Agents, Phytogenic; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cervix Uteri; Etoposide; Female; Humans; Polyps; Pregnancy; Pregnancy Complications, Neoplastic; Treatment Outcome; Uterine Cervical Neoplasms	2009
Prognostic factors in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. Oncology, 2009, Volume: 76, Issue:5 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Deoxycytidine; Disease Progression; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Medical Records; Neoplasm Staging; Paclitaxel; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Vinblastine; Vinorelbine	2009
Postoperative recurrence and the role of adjuvant chemotherapy in patients with pulmonary large-cell neuroendocrine carcinoma. The Journal of thoracic and cardiovascular surgery, 2009, Volume: 138, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis	2009
Methylation induced gene silencing of HtrA3 in smoking-related lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Jan-15, Volume: 16, Issue:2 Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Cells, Cultured; Cisplatin; DNA Methylation; Drug Resistance, Neoplasm; Etoposide; Gene Silencing; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Nitrosamines; Serine Endopeptidases; Smoking	2010
Cisplatin combination chemotherapy induces oxidative stress in advance non small cell lung cancer patients. Asian Pacific journal of cancer prevention : APJCP, 2010, Volume: 11, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Case-Control Studies; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Lipid Peroxidation; Lung Neoplasms; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Superoxide Dismutase; Survival Rate; Treatment Outcome	2010
Large cell neuroendocrine carcinoma arising from the left main bronchus. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:18 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Bronchoscopy; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Neoplasm Staging; Tomography, X-Ray Computed; Treatment Outcome	2011
Implications of delayed initiation of radiotherapy: accelerated repopulation after induction chemotherapy for stage III non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:11 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Induction Chemotherapy; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Retrospective Studies; Time Factors; Tomography, X-Ray Computed	2011
Effect of chemotherapy in patients with resected small-cell or large-cell neuroendocrine carcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2012, Volume: 7, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Lymph Nodes; Male; Methotrexate; Middle Aged; Neoplasm Staging; Perioperative Care; Platinum; Pneumonectomy; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate	2012
Tumor cavitation in patients with stage III non-small-cell lung cancer undergoing concurrent chemoradiotherapy: incidence and outcomes. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2012, Volume: 7, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Deoxycytidine; Etoposide; Female; Follow-Up Studies; Gemcitabine; Hemorrhage; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Prognosis; Pulmonary Embolism; Retrospective Studies; Risk Factors; Survival Rate	2012
Large cell neuroendocrine carcinoma (LCNEC) of the urinary bladder: a case report. Diagnostic pathology, 2013, Feb-04, Volume: 8 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Etoposide; Fatal Outcome; Female; Humans; Immunohistochemistry; Middle Aged; Neoadjuvant Therapy; Treatment Outcome; Urinary Bladder Neoplasms	2013
Complexity in the treatment of pulmonary large cell neuroendocrine carcinoma. Journal of cancer research and clinical oncology, 2005, Volume: 131, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Large Cell; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroendocrine Tumors; Quinazolines; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Failure; Treatment Outcome	2005
Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy. Lung cancer (Amsterdam, Netherlands), 2005, Volume: 49, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Treatment Outcome; Vindesine	2005
Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I in a patient with metastasizing large-cell carcinoma of the lung. The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:5 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Carboplatin; Carcinoma, Large Cell; Chromatography, Gel; Etoposide; Female; Human Growth Hormone; Humans; Hypoglycemia; Immunohistochemistry; In Situ Hybridization; Insulin; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Paraneoplastic Endocrine Syndromes; Reverse Transcriptase Polymerase Chain Reaction; RNA	2007
Isolated metastasis of lung cancer to the thyroid gland. Lung cancer (Amsterdam, Netherlands), 2007, Volume: 58, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Large Cell; Carcinoma, Small Cell; CD56 Antigen; Chemotherapy, Adjuvant; Chromogranin A; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Irinotecan; Lung Neoplasms; Male; Thyroid Neoplasms	2007
Effect of platinum combined with irinotecan or paclitaxel against large cell neuroendocrine carcinoma of the lung. Japanese journal of clinical oncology, 2007, Volume: 37, Issue:7 Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Docetaxel; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Retrospective Studies; Taxoids; Vinblastine; Vinorelbine	2007
[Early results of chemotherapy in patients with non-small cell lung cancer]. Pneumonologia i alergologia polska, 1996, Volume: 64, Issue:11-12 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Remission Induction; Treatment Outcome	1996
Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients. International journal of radiation oncology, biology, physics, 1999, May-01, Volume: 44, Issue:2 Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Proportional Hazards Models; Regression Analysis; Retrospective Studies; Survival Analysis; Vinblastine	1999